Cohance Lifesciences Q2 Results: Net profit plunges 80% on lower revenue, unfavourable product mix

Cohance Life Sciences reported a 79.5% year-on-year decline in Q2 FY27 net profit to ₹15.2 crore, while revenue fell 14.2% to ₹477 crore. The company expects a materially stronger…

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)